SynthesisBMC neurology2025
Machine learning-based models in prediction of the radiological outcomes of vestibular schwannoma following stereotactic radiosurgery: a systematic review and meta-analysis.
Synthesis in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrediction of the radiological outcomes of the vestibular schwannomas (VSs) following stereotactic radiosurgery (SRS) is critical in the management of these lesions. Predictions of tumor control can optimize therapeutic strategies and enhance treatment outcomes. Significant advancements in machine learning (ML) have led to the development of models to predict the radiological outcomes after SRS in VS individuals. This study evaluated the role of ML-based models in predicting the radiological outcomes of SRS in the setting of VS.
methodsOn December 12, 2024, the four electronic databases, Pubmed, Embase, Scopus, and Web of Science, were systematically searched. Studies that evaluated the performance outcomes of the ML-based predictive models were included. The pooled sensitivity, specificity, area under the curve (AUC), and diagnostic odds ratio (DOR) were calculated through the R program. The hierarchical summary receiver operating characteristic (HSROC) model was utilized to form a summary ROC (SROC) curve.
resultsNine studies with 1095 patients were included. Most of the best performance models were ML-based (88.9 8/9). The most frequent algorithm was the support vector machine (SVM) (44.4%, 4/9). The meta-analysis revealed a pooled sensitivity rate of 86% (95%CI: 83-89%), a specificity rate of 78% (95%CI: 62-89%), and a DOR of 19.8 (95%CI: 9.12-42.9). The SROC curve exhibited an AUC of 0.845 for tumor response prediction.
conclusionClinical application of ML-based predictive models can optimize the therapeutic strategy and enhance the outcomes for patients with VS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.